Duodenocaval fistula after treatment with bevacizumab
Med Clin (Barc). 2019 Oct 11;153(7):303.
doi: 10.1016/j.medcli.2019.04.008.
Epub 2019 Jun 5.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitari Vall d'Hebron, Barcelona, España. Electronic address: annacurell2@gmail.com.
- 2 Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitari Vall d'Hebron, Barcelona, España.
- 3 Unidad de Cirugía Colorrectal, Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitari Vall d'Hebron, Barcelona, España; Departamento de Cirugía y Ciencias Morfológicas, Universitat Autònoma de Barcelona, Barcelona, España.
No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents, Immunological / adverse effects*
-
Bevacizumab / adverse effects*
-
Carcinoma, Squamous Cell / therapy
-
Combined Modality Therapy / methods
-
Duodenal Diseases / chemically induced*
-
Duodenal Diseases / diagnostic imaging
-
Female
-
Humans
-
Intestinal Fistula / chemically induced*
-
Intestinal Fistula / diagnostic imaging
-
Uterine Cervical Neoplasms / therapy
-
Vascular Fistula / chemically induced*
-
Vascular Fistula / diagnostic imaging
-
Venae Cavae* / diagnostic imaging
Substances
-
Antineoplastic Agents, Immunological
-
Bevacizumab